Mr Anirudh Suresh

Chelsea and Westminster Hospital NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia

Presentation

PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia

ESC 365 is supported by

novartis

Explore sponsored resources